Navigation Links
MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014

WILMINGTON, Delaware, September 1 /PRNewswire/ -- According to a new market research report, 'Global Autoimmune Treatment Market (2009-2014)', published by MarketsandMarkets (, the global autoimmune treatment market is expected to be worth US$68.81 billion by 2014, with an estimated CAGR of 12.7% from 2009 to 2014. The North American market is expected to account for nearly 42% of the total revenues.

Browse 100+ market data tables and in-depth TOC on autoimmune treatment market.

Early buyers will receive 10% customization of reports


(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

Autoimmune disorders result from an overactive immune response of a body working against its own cells. The disease is broadly classified into two types: systemic autoimmune diseases, which affect several organs of the body; and localized autoimmune diseases, which affect only one organ. Around 80 autoimmune diseases are recognized under these two categories. The disease affected over 300 million people across the globe in 2009. No defined reasons have been discovered to date for the occurrence of the disorder. Women are more prone to autoimmune diseases, constituting 70%-75% of all autoimmune patients.

The global market for autoimmune disease treatments is estimated to be at $37.84 billion in 2009 and is growing at a CAGR of 12.7% from 2009 to 2014. The market is forecasted to be at $68.81 billion in 2014. The effects of the global meltdown are given careful consideration when forecasting the market. As autoimmune disorders still have no permanent cure, more and more pharmaceutical companies are making significant R&D investments into finding treatments for autoimmune diseases, are also focusing on finding the causes behind the disease, which again are unknown.

The overall market for the treatment of autoimmune disorders is analyzed into the submarkets for applications, products, services, and technologies. The application market is further classified into the treatment markets for systemic autoimmune diseases and localized autoimmune diseases. The applications market is dominated mostly by rheumatoid arthritis under the systemic disease segment, while multiple sclerosis is the major application market under the localized disease segment. These two disorders account for 75% of the total applications market. The other major diseases analysed under the application market are psoriasis, lupus, type I diabetes, inflammatory bowel disease, and thyroid disorders, which together account for 15%-20% of the global applications market.

The product market is classified on the basis of the drugs, diagnostic equipments, therapeutic and monitoring equipment. Drugs form the largest segment of the products market, with major drugs such as NSAID, DMARD, biologic DMARD, Avonex, Rebif, Copaxone, Betaseron, and 5-ASA. The services market consists of consultation and diagnosis, therapy and monitoring, and drug development. The wide and increasing prevalence of autoimmune diseases is boosting the drugs market along with the therapy and monitoring market; along with the fact that almost all autoimmune diseases are chronic and have no permanent cure.

Scope of the Report

The report provides market overviews, market forecasts, market drivers and restraints for the autoimmune treatment market. In addition, the report profiles the top forty market players and their respective autoimmune products. The report identifies and analyzes the market according to application markets for both systemic and localized autoimmune diseases, product markets, services market, and technologies market.

    Autoimmune Treatment - Applications

    - Systemic autoimmune diseases - rheumatoid arthritis, psoriasis, lupus
    and other systemic autoimmune diseases.

    - Localized autoimmune diseases - multiple sclerosis, inflammatory bowel
    disease, diabetes, thyroid and other localized autoimmune diseases.

Autoimmune Treatment - Products

Drugs, diagnostic equipments, therapeutic and monitoring equipments and other products.

Autoimmune Treatment - Services

Consultation & Diagnosis, Therapy & Monitoring, Drug Development and other services.

Autoimmune Treatment - Technologies

DMARD (disease-modifying anti-rheumatic drugs) and biologic DMARD therapy, Bridge therapy, Topical therapy, Phototherapy, Helminthic therapy, Fecal bacteriotherapy, Haematopoietic stem-cell transplantation, Recombinant technology

Analyst Briefings on 15th Sep 2009.

The Pharmaceuticals practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global Autoimmune Treatment Market to be held on 15th Sep 2009. The briefing on the Global Autoimmune Treatment Market (2009-2014) will benefit the drug manufacturers, therapeutic and diagnostic equipment manufacturers, researchers and consultation and therapy service providers.

To register your participation, please click here aterial-market.asp

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

Contact our representative to sponsor this report

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market research reports ( per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at

    Ms. Sunita
    108, West 13th Street,
    Wilmington, DE, 19801
    County of New Castle
    Tel: +1-888-989-8004

SOURCE Markets and Markets
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Global Biomaterials Market Worth US$58.1 Billion by 2014
2. Tianyin Pharmaceutical, Co. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 11 at 10:50 am ET
3. Elsevier Global Medical News Launches H1N1 Channel
4. NexInfo Solutions, Inc. Selected by Beckman Coulter to Design and Streamline Global Sales & Operations Planning Processes
5. PharmatrophiX, Initially Funded by the Alzheimers Drug Discovery Foundation, Announces Exclusive Global Collaboration with Elan
6. AEterna Zentaris to Present at Upcoming Canaccord Adams 29th Annual Global Growth Conference
7. Orexigen(R) Therapeutics to Speak at Canaccord Adams Global Growth Conference
8. VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
9. Optimer Pharmaceuticals to Present at the Canaccord Adams 29th Annual Global Growth Conference
10. Global Jatropha Hi-Tech Agricultural Training Programme (JWTP)
11. Global One Consulting Announces Exclusive Contract to Expand Saigene Biotech, Inc. Sales in Emerging Markets
Post Your Comments:
(Date:11/30/2015)... , December 1, 2015 Partnership includes an ... for the u niversity , ... support treatment s cale - up ... (ARVs)   Africa , where licensees based anywhere in the ... on SDN technology. --> Africa , where licensees based anywhere ...
(Date:11/30/2015)... Mass. , Nov. 30, 2015 ... HART ), a biotechnology company developing bioengineered organ ... received written notification from The NASDAQ Stock Market ... bid price requirements. The letter noted that as ... HART,s common stock having exceeded $1.00 per share ...
(Date:11/30/2015)... BETHESDA, Md. , Nov. 30, 2015 /PRNewswire/ ... property development company committed to the fostering and ... on the current and prospective initiatives designed to ... , Chief Executive Officer of Spherix. "Based on ... potential future licensees exceeds $50 billion and Spherix ...
(Date:11/30/2015)... 30, 2015  Champions Oncology, Inc. (CSBR), engaged in ... personalize the development and use of oncology drugs, today ... will be presenting at the LD MICRO Investor Conference ... Time (PST).  The conference, held at the Luxe Sunset ... , will feature 200 small/micro-cap companies and is ...
Breaking Biology Technology:
(Date:11/19/2015)... , Nov. 19, 2015  Based on its ... & Sullivan recognizes BIO-key with the 2015 Global Frost ... year, Frost & Sullivan presents this award to the ... catering to the needs of the market it serves. ... line meets and expands on customer base demands, the ...
(Date:11/18/2015)... 2015  As new scientific discoveries deepen our understanding ... healthcare providers face challenges in better using that knowledge ... addition, as more children continue to survive pediatric cancer, ... old age. John M. Maris, M.D ., ... Philadelphia (CHOP) . --> John M. ...
(Date:11/17/2015)... Paris from 17 th until ... from 17 th until 19 th November ... has invented the first combined scanner in the world which scans ... Until now two different scanners were required: one for passports ... on the same surface. This innovation is an ideal solution ...
Breaking Biology News(10 mins):